IRCT20150101020514N8
Recruiting
Phase 2
Comparative evaluation of the safety and efficacy of botulinum toxin type A (product of Imen Vaccine Alborz CO) in comparison with Dysport (standard treatment) for treating glabellar rhytids in people with moderate to severe glabellar rhytids.
Imen vaccine alborz Company0 sites140 target enrollmentTBD
Conditionsskin rejuvenation.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- skin rejuvenation.
- Sponsor
- Imen vaccine alborz Company
- Enrollment
- 140
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Men and women with 18 to 75 years old
- •mild to moderate Glabellar Lines
- •signing informed consent form
Exclusion Criteria
- •Hypersensitivity to botulinum toxin or other components of formulation
- •History of treatment with botulinum toxin in face area within the past 6 months
- •History of using aminoglycosides, penicillin, kinin, chloroquine,Calcium Channel Blockers, warfarin and aspirin
- •History of injectable filler, chemical peels and laser treatment of any type within the past year
- •Significant scarring ,skin disorder or wound infection in the facial area
- •Neuro\-muscular disorders like miastenia gravis, iron lambert , ALS
- •Significant face asymmetry
- •Any active, chronic and recurrent infection
- •Pregnancy/ breast feeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparative evaluation of the safety and efficacy of long term use of anti-cholinergic, Imidafenacin and Solifenacin, on overactive bladder: a prospective randomized trial.overactive bladderJPRN-UMIN000004354Department of Urology, Kanto Rosai Hospital60
Active, not recruiting
Not Applicable
Dexmedetomedine intravenous sedation on patients with and without Beta blockersHealth Condition 1: null- Retinal Disorder Patients requiring SurgeryHealth Condition 2: H431- Vitreous hemorrhageCTRI/2018/08/015387ETHRADHAMA SUPER SPECIALITY EYE HOSPITA
Recruiting
Phase 3
Comparative assessment of the efficacy and safety of add ontreatment with Sofosbuvir standard of care therapeutic regimenVelpatasvir” to standard of caretherapeutic regimen” in patients with COVID-19COVID-19.COVID-19 diseaseU07.1IRCT20130812014333N145Kermanshah University of Medical Sciences80
Recruiting
Phase 3
Comparative assessment of the efficacy and safety of addon treatment with Sofosbuvir-Daclatasvir”, Lithium”,and Trifluoprazine” to standard of care in three groups of patients with COVID-19IRCT20130812014333N147Kermanshah University of Medical Sciences80
Not yet recruiting
Phase 4
Comparison of adhesive and suture in skin closure following small incision abdominal surgery(laparoscopic)CTRI/2024/07/070591Adichunchanagiri Institute Of Medical Sciences